Drug Approval | March 14, 2022
USFDA approves Zydus’ Colestipol Hydrochloride tablets
It is only the second generic application approved by the USFDA
It is only the second generic application approved by the USFDA
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
Govt announces vaccination programme for kids and those above 60 years of age
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
The product will be manufactured at Lupin’s facility in Goa, India
Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Subscribe To Our Newsletter & Stay Updated
